ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2020
Long-term follow-up results and complications in cancer patients with persistent nephrostomy due to malignant ureteral obstruction.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 21 citations in OpenAlex.
- Percutaneous nephrostomy as a marker of clinical vulnerability in non-metastatic muscle-invasive bladder cancer: prognostic and infectious implications.Frontiers in oncology · 2026Article
- Antibiotic prophylaxis in percutaneous nephrostomy placements and replacements for malignant urinary tract obstruction. Retrospective cohort study with systematic review and meta-analysis.Frontiers in radiology · 2026Review
- Predictive factors for spontaneous dislodgement of percutaneous nephrostomies for malignant ureteral obstruction.Abdominal radiology (New York) · 2025Article
- Predictors of Nephrostomy Catheter Dislodgement: Insights from a Retrospective Analysis.Cardiovascular and interventional radiology · 2025Article
- The effect of urinary diversion on kidney function in posterior urethral valves and ureterovesical obstruction.International urology and nephrology · 2025Article
- Nephrostomy tubes for management of a bladder occupying embryonal rhabdomyosarcoma in a 2-year-old: A case report and review of the literature.Urology case reports · 2025Article
- Time-sensitive elements in elective treatment of urinary lithiasis: a narrative review.Translational andrology and urology · 2025Review
- Effect of emergent nephrostomy on long-term total and split renal function in patients with upper urinary tract obstruction due to pelvic malignant tumors.Pediatric surgery international · 2024Article
- High early mortality following percutaneous nephrostomy in metastatic cancer: a national analysis of outcomes.BMJ supportive & palliative care · 2024Article
- Malignant upper urinary tract obstruction in cancer patients: A systematic review.BJUI compass · 2024Review
- The Current Status of Palliative Care, Hospice, and End-of-Life Health Care Utilization in Patients With Malignant Ureteral Obstruction.Urology practice · 2024Article
- Allium covered metal stent for treatment of malignant ureteral obstruction.Frontiers in surgery · 2024Article
- Quality of life with tandem ureteral stents compared to percutaneous nephrostomy for malignant ureteral obstruction.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe aimed to evaluate the long-term complications and predisposing factors for these complications in patients with malignant ureteral obstruction (MUO) treated with percutaneous nephrostomy (PN).
methodsThe records of patients with MUO treated with PN between January 2015 and 2018 were retrospectively reviewed for PN dislodgement, PN obstruction, PN replacement, pyelonephritis, hospitalizations due to PN complications, and other complications due to PN such as macroscopic hematuria, skin infections, or renal/perirenal abscess.
resultsData for a total of 147 patients (229 renal units [RU], 107 males, 40 females) were evaluated. In 174 (76%) RU, PN was replaced due to PN dislodgement. The predisposing factors for PN dislodgement were follow-up time, body mass index (BMI), chemotherapy, diabetes mellitus (DM), low educational level (LEL), pyelonephritis, and catheter-related skin infections (CSRI). The PN was replaced in 40 RU due to obstruction. The predisposing factors for obstruction were follow-up time and BMI. Pyelonephritis developed at least once in 61 (41.5%) patients. Follow-up time, BMI, previous surgery, DM, and LEL were the predisposing factors for pyelonephritis. CSRI developed in 16 RU. Follow-up time, BMI, DM, and LEL were the predisposing factors for CSRI. Macroscopic hematuria developed in 11 patients. Follow-up time, previous surgery, DM, chemotherapy, and LEL were predisposing factors for macroscopic hematuria.
conclusionThe most common complication in patients with MUO treated with PN was PN dislodgement. However, life-threatening complications such as macroscopic hematuria and severe infections can also occur. Patients with DM, LEL, and chemotherapy are at high risk of PN-related complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.